Archives: Speakers

Floriane Reinaud started her carrier in pharmaceutical pricing, reimbursement and market access. She has oversees several datasets including prices of medicines, costs of treatments, HTA decisions, International Reference Pricing. Over the years she has expanded her expertise into clinical trials, manufacturers, sales forecasts and is now the Senior Director of the Databases and Analytics at GlobalData.

She studied biology and holds a Master of Science in biochemistry, as well as a Master of Science in healthcare marketing. She co-authored a peer-reviewed article that was published in The Journal of Biological Biochemistry.

She speaks English and French (her mother tongue).

Clare Campbell-Cooper joined Fortrea in February 2020 and serves as its Global Head of Digital Health and Innovation. Clare has over 25 years of industry experience and is a recognized leader within the field of digital health. Clare has a wealth of experience encompassing many disciplines within clinical research and has held management positions within Data Management, Clinical Monitoring, Phase I Operations, Strategy and Planning, Project Management and, most recently, Digital Health.

Clare is an active member a number of boards and associations and sees that working in a pre-competitive environment is critical to helping drive change within the industry. Clare is passionate about how we can change clinical trials for the better and is a member of the Fortrea Environmental Sustainability Committee a founding member of the Fortrea Sustainable Future Chapter and Co-Chair on ACRO’s Sustainable Clinical Trials Committee. Clare sits on the Kings College London Scientific Advisory Board, Centre for Pharmaceutical Medicine Research and is a visiting lecturer at KCL.

In her role as Global Head of Digital Health and Innovation at Fortrea Clare is helping to change the face of how clinical research is developing. She specialises in strategy development for both internal and external partners. Clare’s special interest lies in the relationship between the caregiver and physician team and how the use of digital technology can augment this.

Rikin “Rik” Mehta—CEO & Co-Founder of Lactiga, a biotechnology company developing therapies from human milk antibodies for rare immunodeficiencies. Rik also teaches international drug law and regulation at Georgetown University Law Center and Mount St. Mary’s University, is a former FDA official, and made history as the first Indian-American nominee for U.S. Senate in New Jersey, where he also set a record for the highest number of votes ever received by his party’s candidate.

Akira Shibata leads the APAC region at Weights & Biases, the industry-standard platform for MLOps and LLMOps. He specializes in driving AI value creation across diverse industries, from generative AI to financial services. An accomplished entrepreneur and data scientist, Akira holds a Ph.D. in Physics from the University of London and has served as CEO of DataRobot Japan and COO of Qosmo, Inc. LinkedIn profile: https://www.linkedin.com/in/akirashibata/

Reto Cueni joined Syz Group in June 2025 as Chief Economist. He previously served as Chief Economist at Vontobel Group from 2020, having been part of Vontobel Asset Management’s Investment Strategy team since 2014 as a Senior Economist.

From 2009 to 2014, Reto worked as a researcher and lecturer in the Department of Economics at the University of Zurich. His academic work earned him a research fellowship from the Swiss National Science Foundation at Columbia University in New York. He began his career in finance as an equity analyst at Vontobel Equity Research in 2005. He continues to serve as a guest lecturer at the University of Zurich.

Ian is a part time board/executive advisor to wealth managers, technology providers and Strategy Advisor to Multrees Investor Services.

He assists founders, boards and executives to better respond to industry complexity, uncertainty, speed of change in client expectations, technology advancements etc. which could impact their current strategy, execution and performance.

Previously with EY, PwC, IBM, Orbium, a privately held Swiss core banking implementor, sold to Accenture, experience includes working across wealth industry sub sectors, business models, geographies, firms of various sizes, at different points in their lifecycles. Can adjust to firm specific circumstances in a collaborative, cross functional and joined up way to help resolve their key strategic, client, advisor, operating model, technology issues. Provides outside in, aligned view of current, future key opportunities and challenges to help strengthen decision making, governance, communication priorities and in orchestrating an adaptive, resilient, innovative evolution path to deliver higher performance.